Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2.
J Clin Virol
; 142: 104912, 2021 09.
Article
in En
| MEDLINE
| ID: mdl-34298379
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
Limits:
Humans
Language:
En
Journal:
J Clin Virol
Journal subject:
VIROLOGIA
Year:
2021
Type:
Article
Affiliation country:
Germany